Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Best of ASCO® Miami 2017 /
Identifying rare mutations in lung cancer

14th - 16th Jul 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.07.17
Views: 1369
Rating:

Dr Raymond Osarogiagbon - Baptist Cancer Center, Memphis, Tennessee, USA

Dr Osarogiagbon speaks with ecancer at the Best of ASCO meeting in Miami to discuss rare mutations in lung cancer.

He highlights the clinical significance of rare genotypes for treatment selection and prognosis, encouraging the routine testing of patient samples.

Dr Luis Raez also spoke with ecancer in Miami about advances in lung cancer care.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation